Home - Products - Others - Other Targets - β-Amyloid/A4 Protein Precursor (APP) (96-110), analog

β-Amyloid/A4 Protein Precursor (APP) (96-110), analog

CAS No. ———

β-Amyloid/A4 Protein Precursor (APP) (96-110), analog( ——— )

Catalog No. M40703 CAS No. ———

β-Amyloid/A4 Protein Precursor (APP) (96-110), analog

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    β-Amyloid/A4 Protein Precursor (APP) (96-110), analog
  • Note
    Research use only, not for human use.
  • Brief Description
    β-Amyloid/A4 Protein Precursor (APP) (96-110), analog
  • Description
    β-Amyloid/A4 Protein Precursor (APP) (96-110), analog
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    1918.25
  • Molecular Formula
    C81H128N32O19S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 5A/5B Peptide (3)

    Ac-EEVVAC-pNA is a chromogenic substrate for a continuous spectrophotometric assay of HCV NS3 protease. The sequence EEVVAC is derived from the 5A-5B cleavage junction of the HCV polyprotein.

  • PACAP (1-38), human,...

    PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP), gastrin releasing peptide (GRP), and VIP release. PACAP 1-38 (10-8 M) inhibited gastrin secretion and stimulated somatostatin secretion and motility dose-dependently.

  • Lomibuvir

    Lomibuvir (VCH-222) is a selective, non-nucleoside allosteric inhibitor of HCV NS5B polymerase (RdRp) with a Kd of 17 nM. Lomibuvir inhibits the 1b/Con1 HCV subgenomic replicon with an EC 50 of 5.2 nM.